Anorexia in older persons - Epidemiology and optimal treatment

被引:76
作者
Morley, JE [1 ]
机构
[1] VET ADM MED CTR, CTR GERIATR RES EDUC & CLIN, ST LOUIS, MO 63125 USA
关键词
D O I
10.2165/00002512-199608020-00007
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Anorexia and weight loss are common findings in older persons. Over a lifetime, normal persons decrease their food intake to counterbalance the decrease in physical activity and resting metabolic rate that occurs with aging. This physiological anorexia of aging increases the propensity to develop pathological anorexia and weight loss when an older person develops either a medical or psychological illness. The physiological anorexia of aging is due to a decreased opioid (dynorphin) feeding drive and an increase in the satiating effect of the gastrointestinal hormone, cholecystokinin. Nitric oxide deficiency may play a role in the early satiation commonly seen in older persons. A variety of social, psychological and medical conditions can lead to pathological anorexia. Depression is the most common cause of weight loss and anorexia in older persons. A number of conditions such as cancer and rheumatoid arthritis produce their anorectic and wasting effects by releasing cytokines. An idiopathic pathological senile anorexia has been characterised which also appears to be a cytokine-dependent syndrome. Early screening for malnutrition is a cornerstone of the management of anorexia; the Mini Nutritional Assessment is a well validated screening tool available for this purpose. Aggressive use of caloric supplements, enteral tube feeding and peripheral parenteral nutrition all have a role in the early management of anorexia. Numerous drugs (growth hormone, megestrol, cyproheptadine, tetrahydrocannabinol, anabolic steroids, prokinetic agents and antidepressants) have been utilised to treat the anorexia of aging with varying success.
引用
收藏
页码:134 / 155
页数:22
相关论文
共 206 条
[81]  
KRAUSE R, 1979, CANCER, V44, P1003, DOI 10.1002/1097-0142(197909)44:3<1003::AID-CNCR2820440330>3.0.CO
[82]  
2-3
[83]  
KRENTZ AJ, 1993, J ACQ IMMUN DEF SYND, V6, P245
[84]  
KRIS MG, 1985, P AN M AM SOC CLIN, V4, pA1038
[85]   EFFECT OF DIETARY-SUPPLEMENT ON NUTRITIONAL-STATUS AND CLINICAL OUTCOME IN 501 GERIATRIC-PATIENTS - A RANDOMIZED STUDY [J].
LARSSON, J ;
UNOSSON, M ;
EK, AC ;
NILSSON, L ;
THORSLUND, S ;
BJURULF, P .
CLINICAL NUTRITION, 1990, 9 (04) :179-184
[86]   NEUROCHEMICAL NEUROENDOCRINE SYSTEMS IN THE BRAIN CONTROLLING MACRONUTRIENT INTAKE AND METABOLISM [J].
LEIBOWITZ, SF .
TRENDS IN NEUROSCIENCES, 1992, 15 (12) :491-497
[87]   HEPATIC PORTAL GLUCAGON-INFUSION DECREASES SPONTANEOUS MEAL SIZE IN RATS [J].
LESAUTER, J ;
GEARY, N .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (01) :R154-R161
[88]   PERIPHERALLY ADMINISTERED SOMATOSTATIN REDUCES FEEDING BY A VAGAL MEDIATED MECHANISM [J].
LEVINE, AS ;
MORLEY, JE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1982, 16 (06) :897-902
[89]   THE EFFECT OF PROSTAGLANDINS (PGE2 AND PGF2-ALPHA) ON FOOD-INTAKE IN RATS [J].
LEVINE, AS ;
MORLEY, JE .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1981, 15 (05) :735-738
[90]   ENERGY-EXPENDITURE AND WASTING IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
MACALLAN, DC ;
NOBLE, C ;
BALDWIN, C ;
JEBB, SA ;
PRENTICE, AM ;
COWARD, WA ;
SAWYER, MB ;
MCMANUS, TJ ;
GRIFFIN, GE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (02) :83-88